These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 39049168)
1. HIV remains a deadly companion to drug-resistant TB in Ukraine. Dahl VN; Butova T; Kuzhko M; Sapelnik N; Borysova O; Pedersen OS; Butov D Int J Tuberc Lung Dis; 2024 Aug; 28(8):400-402. PubMed ID: 39049168 [No Abstract] [Full Text] [Related]
2. Towards a new health diplomacy in eastern Ukraine. Kazatchkine M Lancet HIV; 2017 Mar; 4(3):e99-e101. PubMed ID: 28254150 [No Abstract] [Full Text] [Related]
3. Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics? Dubrovina I; Miskinis K; Lyepshina S; Yann Y; Hoffmann H; Zaleskis R; Nunn P; Zignol M Int J Tuberc Lung Dis; 2008 Jul; 12(7):756-62. PubMed ID: 18544200 [TBL] [Abstract][Full Text] [Related]
4. Treatment outcomes of drug-resistant tuberculosis in people living with HIV in Odesa province, Ukraine, 2014-2016. Yesypenko S; Grigoryan R; Sereda Y; Denisuk O; Kovtunovich L; Rybak T; Postnov O; Neduzhko O; Antonyak S; Bespoyasnaya V J Infect Dev Ctries; 2020 Nov; 14(11.1):88S-93S. PubMed ID: 33226965 [TBL] [Abstract][Full Text] [Related]
5. Managing multiple and extensively drug-resistant tuberculosis and HIV. Padayatchi N; Friedland G Expert Opin Pharmacother; 2007 Jun; 8(8):1035-7. PubMed ID: 17516869 [TBL] [Abstract][Full Text] [Related]
6. Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey. Pavlenko E; Barbova A; Hovhannesyan A; Tsenilova Z; Slavuckij A; Shcherbak-Verlan B; Zhurilo A; Vitek E; Skenders G; Sela I; Cabibbe AM; Cirillo DM; de Colombani P; Dara M; Dean A; Zignol M; Dadu A Int J Tuberc Lung Dis; 2018 Feb; 22(2):197-205. PubMed ID: 29506617 [TBL] [Abstract][Full Text] [Related]
7. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia. Walls G; Bulifon S; Breysse S; Daneth T; Bonnet M; Hurtado N; Molfino L Glob Health Action; 2015; 8():25964. PubMed ID: 25623609 [TBL] [Abstract][Full Text] [Related]
9. Predictors of mortality and treatment success of multi-drug resistant and Rifampicin resistant tuberculosis in Zimbabwe: a retrospective cohort analysis of patients initiated on treatment during 2010 to 2015. Matambo R; Nyandoro G; Sandy C; Nkomo T; Mutero-Munyati S; Mharakurwa S; Chikaka E; Ngwenya M; Ndongwe G; Pepukai VM Pan Afr Med J; 2021; 39():128. PubMed ID: 34527144 [TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant tuberculosis in Ukraine at a time of military conflict. Dudnyk A; Rzhepishevska O; Rogach K; Kutsyna G; Lange C Int J Tuberc Lung Dis; 2015 Apr; 19(4):492-3. PubMed ID: 25860008 [No Abstract] [Full Text] [Related]
11. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa. Umanah TA; Ncayiyana JR; Nyasulu PS Trans R Soc Trop Med Hyg; 2015 May; 109(5):340-8. PubMed ID: 25787727 [TBL] [Abstract][Full Text] [Related]
12. Tuberculosis in times of war and crisis: Epidemiological trends and characteristics of patients born in Ukraine, Germany, 2022. Hauer B; Kröger S; Haas W; Brodhun B Euro Surveill; 2023 Jun; 28(24):. PubMed ID: 37318760 [TBL] [Abstract][Full Text] [Related]
13. HIV and MDR-TB in Ukraine: news from a hazardous MDR-TB and HIV site. Granich R Int J Tuberc Lung Dis; 2008 Jul; 12(7):701. PubMed ID: 18544189 [No Abstract] [Full Text] [Related]
14. Status of HIV and comorbidities in refugees with HIV from Ukraine. Ahrenstorf G; Dopfer-Jablonka A; Joean O; Knuth C; Silchmueller M; Thiele T; Ringshausen FC; Slevogt H; Witte T; Behrens GMN HIV Med; 2024 Apr; 25(4):479-483. PubMed ID: 38043508 [TBL] [Abstract][Full Text] [Related]
15. Tackling the MDR-TB epidemic in Ukraine: every little helps … and much more needed. Burman M; Nikolayevskyy V; Kontsevaya I; Molina-Moya B; Rzhepishevska O; Guglielmetti L J Public Health (Oxf); 2018 Mar; 40(1):210-211. PubMed ID: 28334761 [No Abstract] [Full Text] [Related]
17. Disruption to TB services in Ukraine: less than feared. Holt E Lancet Infect Dis; 2022 Oct; 22(10):1427. PubMed ID: 36152659 [No Abstract] [Full Text] [Related]
18. A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection? Berhan A; Berhan Y; Yizengaw D Ethiop J Health Sci; 2013 Nov; 23(3):271-82. PubMed ID: 24307827 [TBL] [Abstract][Full Text] [Related]
19. Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection. Sagwa E; Ruswa N; Musasa JP; Mantel-Teeuwisse AK Drug Saf; 2013 Nov; 36(11):1087-96. PubMed ID: 23917883 [TBL] [Abstract][Full Text] [Related]
20. Association between antiretroviral therapy and antitubercular drug resistance in TB treatment outcome among Kazakh TB/HIV co-infected patients. Mishkin K; Alaei K; Alikeyeva E; Paynter C; Aringazina A; Alaei A J Glob Antimicrob Resist; 2018 Sep; 14():104-108. PubMed ID: 29496619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]